EUVIMEDEUVIMED entdecken
Validierungsstudie

Cost-effective optimisation and validation of the VISAGE enhanced tool assay on the Illumina NovaSeq 6000 platform

Lauren Verstraeten, Kristina Fokias, Gitte Saerens, Bram Bekaert

Forensic Science International: Genetics · 2025-06 · 78 · 103299

DOI: 10.1016/j.fsigen.2025.103299 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Forensic Science International: Genetics, 2025-06. Verfasst von Lauren Verstraeten und 3 weiteren Autor:innen. Beteiligte Einrichtung: UZ Leuven, Laboratory of Forensic Genetics, Leuven, Belgium; KU Leuven, Forensic Biomedical Sciences, Department of Imaging & Pathology, Leuven, Belg…. Hauptthemen laut MEDLINE: DNA Methylation, High-Throughput Nucleotide Sequencing, Aging, Sequence Analysis, DNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous forensic age prediction models based on DNA methylation markers have been developed, each differing in the number of predictive markers, statistical method, biomatrix, and sequencing platform used. This variability highlighted the need for more uniformity in the development of epigenetic clocks. To partially address this need, the VISAGE Consortium introduced the VISAGE enhanced tool assay, a multi-tissue assay that targets eight age-associated genes (ELOVL2, EDARADD, ASPA, FHL2, MIR29B2CHG, KLF14, TRIM59, and PDE4C). So far, three models were built using this assay for age prediction in blood, buccal cells, and bones, based on Illumina MiSeq sequencing data with the v3 reagent kit (2 × 300 bp). Unfortunately, the existing models are neither publicly accessible nor permitted for use in forensic casework. To address this limitation, we developed our own age estimation model utilising the VISAGE enhanced tool assay in combination with the Illumina NovaSeq 6000 platform and the v1.5 reagent kit (2 × 150 bp). By employing the same assay, we streamlined the workflow and enhanced uniformity, as there was no need to identify additional age-associated genes. By adjusting the assay's primer concentrations, we achieved sufficient read depths to accurately determine methylation levels, even for longer amplicons with partial sequencing strand coverage. This modified assay was used to develop an age estimation model in blood (n = 98) with a mean absolute error (MAE) of 3.22 years and root mean squared error (RMSE) of 3.77 years in the test set (n = 30). Overall, this study demonstrated that by adjusting primer concentrations, equal age estimation performances can be achieved with the added benefit of drastically reduced costs and turn-around-time by using a 2 × 150 bp sequencing strategy. Additionally, this study was the first to independently validate the VISAGE enhanced tool assay on a different sequencing platform, exploring its potential for broader applications and partially answering the need for more uniformity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationHigh-Throughput Nucleotide SequencingAgingSequence Analysis, DNAHumansMaleCost-Benefit AnalysisAdultFemaleCyclic Nucleotide Phosphodiesterases, Type 4Middle AgedEdar-Associated Death Domain ProteinTripartite Motif ProteinsKruppel-Like Transcription FactorsYoung AdultAdolescentForensic GeneticsAgedFatty Acid Elongases

Stichwörter der Autor:innen

Age predictionDNA MethylationForensic

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 4Edar-Associated Death Domain ProteinPDE4C protein, humanEDARADD protein, humanELOVL2 protein, humanTripartite Motif ProteinsKruppel-Like Transcription FactorsKLF14 protein, humanFatty Acid Elongases

Autor:innen und Institutionen

  • UZ Leuven, Laboratory of Forensic Genetics, Leuven, Belgium; KU Leuven, Forensic Biomedical Sciences, Department of Imaging & Pathology, Leuven, Belgium.
  • UZ Leuven, Laboratory of Forensic Genetics, Leuven, Belgium; KU Leuven, Forensic Biomedical Sciences, Department of Imaging & Pathology, Leuven, Belgium. Electronic address: bram.bekaert@uzleuven.be.

Förderung

  • Research Foundation Flanders

Zitieren

APA

Verstraeten, L., Fokias, K., Saerens, G., & Bekaert, B. (2025). Cost-effective optimisation and validation of the VISAGE enhanced tool assay on the Illumina NovaSeq 6000 platform. Forensic Science International: Genetics, 78, 103299. https://doi.org/10.1016/j.fsigen.2025.103299

Vancouver

Verstraeten L, Fokias K, Saerens G, Bekaert B. Cost-effective optimisation and validation of the VISAGE enhanced tool assay on the Illumina NovaSeq 6000 platform. Forensic Science International: Genetics. 2025;78:103299. doi:10.1016/j.fsigen.2025.103299

BibTeX
@article{Verstraeten2025,
  author = {Verstraeten, Lauren and Fokias, Kristina and Saerens, Gitte and Bekaert, Bram},
  title = {Cost-effective optimisation and validation of the VISAGE enhanced tool assay on the Illumina NovaSeq 6000 platform},
  journal = {Forensic Science International: Genetics},
  year = {2025},
  volume = {78},
  pages = {103299},
  doi = {10.1016/j.fsigen.2025.103299}
}
Kostenlos starten →